Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC)

: Several studies have investigated the inhibitory effect of melatonin on lung cancer cells. There are no data available on the prognostic impact of melatonin receptors MT1 and MT2 in non-small cell lung cancer (NSCLC). : Immunohistochemical studies of MT1 and MT2 were conducted on NSCLC (N = 786) a...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2019-07, Vol.11 (7), p.1001
Main Authors: Jablonska, Karolina, Nowinska, Katarzyna, Piotrowska, Aleksandra, Partynska, Aleksandra, Katnik, Ewa, Pawelczyk, Konrad, Glatzel-Plucinska, Natalia, Podhorska-Okolow, Marzenna, Dziegiel, Piotr
Format: Article
Language:English
Subjects:
Breast cancer
Cancer therapies
Chemotherapy
Kinases
Lung cancer
Lymph nodes
Malignancy
Melatonin
Melatonin receptors
Metastasis
mRNA
Mutation
Non-small cell lung carcinoma
Phosphorylation
Proteins
Radiation
Small cell lung carcinoma
Smoking
Squamous cell carcinoma
Transcription factors
Tumor cell lines
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c421t-f0374426d9bc0868f343804844406ce5def7bf0d6c925cd619e1af6f4de9d9d3
cites cdi_FETCH-LOGICAL-c421t-f0374426d9bc0868f343804844406ce5def7bf0d6c925cd619e1af6f4de9d9d3
container_end_page
container_issue 7
container_start_page 1001
container_title Cancers
container_volume 11
creator Jablonska, Karolina
Nowinska, Katarzyna
Piotrowska, Aleksandra
Partynska, Aleksandra
Katnik, Ewa
Pawelczyk, Konrad
Glatzel-Plucinska, Natalia
Podhorska-Okolow, Marzenna
Dziegiel, Piotr
description : Several studies have investigated the inhibitory effect of melatonin on lung cancer cells. There are no data available on the prognostic impact of melatonin receptors MT1 and MT2 in non-small cell lung cancer (NSCLC). : Immunohistochemical studies of MT1 and MT2 were conducted on NSCLC (N = 786) and non-malignant lung tissue (NMLT) (N = 120) using tissue microarrays. Molecular studies were performed on frozen fragments of NSCLC (N = 62; real time PCR), NMLT (N = 24) and lung cancer cell lines NCI-H1703, A549 and IMR-90 (real time PCR, western blot). : The expression of both receptors was higher in NSCLC than in NMLT. Higher MT1 and MT2 expression levels (at protein and mRNA) were noted in squamous cell carcinomas (SCC) compared to adenocarcinomas (AC). MT1 immunoexpression decreased as both the tumour size and the cancer stage increased in the whole cohort, while MT2 decreased as the cancer stage increased, with lymph node involvement (in the whole study group) and increasing malignancy grade (in SCC). Higher expression of MT2 was associated with a favorable prognosis. MT2 was an independent prognostic factor for overall survival (OS) in all analyzed NSCLC and in smoking patients. : Our observations may point to the potential prognostic significance of MT2 in NSCLC.
doi_str_mv 10.3390/cancers11071001
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6679108</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2261243384</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-f0374426d9bc0868f343804844406ce5def7bf0d6c925cd619e1af6f4de9d9d3</originalsourceid><addsrcrecordid>eNpdkUtLJDEUhYMo06KuZyeB2eiixrw6qWwEKdQR2gfTvZpNSOfRU1KVtEmV4L83o07Tehe5gfvdwz0cAL5j9JNSic6MDsaljDESGCG8A_YJEqTiXLLdrf8EHOX8iEpRigUX38CEYoolR2If_HlIcRViHloDb_q1NgOMHt66Tg8xtAH-dsath5gyvF1gqIMtncAyuIuhmve662DjyjMbwwo2bwfBk7t5M2tOD8Ge1112Rx_9ACyuLhfNr2p2f33TXMwqwwgeKo-oYIxwK5cG1bz2lNEasZoxhrhxU-u8WHpkuZFkaizH0mHtuWfWSSstPQDn77Lrcdk7a1wYku7UOrW9Ti8q6lZ9noT2r1rFZ8W5kBjVReDkQyDFp9HlQfVtNsWUDi6OWRHCMWGU1qygP76gj3FMobhTZMoEk0QgUaizd8qkmHNyfnMMRupfcupLcmXjeNvDhv-fE30FbRGTYA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2547492707</pqid></control><display><type>article</type><title>Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC)</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Jablonska, Karolina ; Nowinska, Katarzyna ; Piotrowska, Aleksandra ; Partynska, Aleksandra ; Katnik, Ewa ; Pawelczyk, Konrad ; Glatzel-Plucinska, Natalia ; Podhorska-Okolow, Marzenna ; Dziegiel, Piotr</creator><creatorcontrib>Jablonska, Karolina ; Nowinska, Katarzyna ; Piotrowska, Aleksandra ; Partynska, Aleksandra ; Katnik, Ewa ; Pawelczyk, Konrad ; Glatzel-Plucinska, Natalia ; Podhorska-Okolow, Marzenna ; Dziegiel, Piotr</creatorcontrib><description>: Several studies have investigated the inhibitory effect of melatonin on lung cancer cells. There are no data available on the prognostic impact of melatonin receptors MT1 and MT2 in non-small cell lung cancer (NSCLC). : Immunohistochemical studies of MT1 and MT2 were conducted on NSCLC (N = 786) and non-malignant lung tissue (NMLT) (N = 120) using tissue microarrays. Molecular studies were performed on frozen fragments of NSCLC (N = 62; real time PCR), NMLT (N = 24) and lung cancer cell lines NCI-H1703, A549 and IMR-90 (real time PCR, western blot). : The expression of both receptors was higher in NSCLC than in NMLT. Higher MT1 and MT2 expression levels (at protein and mRNA) were noted in squamous cell carcinomas (SCC) compared to adenocarcinomas (AC). MT1 immunoexpression decreased as both the tumour size and the cancer stage increased in the whole cohort, while MT2 decreased as the cancer stage increased, with lymph node involvement (in the whole study group) and increasing malignancy grade (in SCC). Higher expression of MT2 was associated with a favorable prognosis. MT2 was an independent prognostic factor for overall survival (OS) in all analyzed NSCLC and in smoking patients. : Our observations may point to the potential prognostic significance of MT2 in NSCLC.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers11071001</identifier><identifier>PMID: 31319607</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Breast cancer ; Cancer therapies ; Chemotherapy ; Kinases ; Lung cancer ; Lymph nodes ; Malignancy ; Melatonin ; Melatonin receptors ; Metastasis ; mRNA ; Mutation ; Non-small cell lung carcinoma ; Phosphorylation ; Proteins ; Radiation ; Small cell lung carcinoma ; Smoking ; Squamous cell carcinoma ; Transcription factors ; Tumor cell lines ; Tumors</subject><ispartof>Cancers, 2019-07, Vol.11 (7), p.1001</ispartof><rights>2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 by the authors. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-f0374426d9bc0868f343804844406ce5def7bf0d6c925cd619e1af6f4de9d9d3</citedby><cites>FETCH-LOGICAL-c421t-f0374426d9bc0868f343804844406ce5def7bf0d6c925cd619e1af6f4de9d9d3</cites><orcidid>0000-0002-8292-1385 ; 0000-0003-4093-7386 ; 0000-0002-4618-9668 ; 0000-0001-8275-7266 ; 0000-0002-6498-717X ; 0000-0001-6901-1240 ; 0000-0002-7989-3264 ; 0000-0001-8316-8893 ; 0000-0002-7532-0397 ; 0000-0003-2215-5997</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2547492707/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2547492707?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31319607$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jablonska, Karolina</creatorcontrib><creatorcontrib>Nowinska, Katarzyna</creatorcontrib><creatorcontrib>Piotrowska, Aleksandra</creatorcontrib><creatorcontrib>Partynska, Aleksandra</creatorcontrib><creatorcontrib>Katnik, Ewa</creatorcontrib><creatorcontrib>Pawelczyk, Konrad</creatorcontrib><creatorcontrib>Glatzel-Plucinska, Natalia</creatorcontrib><creatorcontrib>Podhorska-Okolow, Marzenna</creatorcontrib><creatorcontrib>Dziegiel, Piotr</creatorcontrib><title>Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC)</title><title>Cancers</title><addtitle>Cancers (Basel)</addtitle><description>: Several studies have investigated the inhibitory effect of melatonin on lung cancer cells. There are no data available on the prognostic impact of melatonin receptors MT1 and MT2 in non-small cell lung cancer (NSCLC). : Immunohistochemical studies of MT1 and MT2 were conducted on NSCLC (N = 786) and non-malignant lung tissue (NMLT) (N = 120) using tissue microarrays. Molecular studies were performed on frozen fragments of NSCLC (N = 62; real time PCR), NMLT (N = 24) and lung cancer cell lines NCI-H1703, A549 and IMR-90 (real time PCR, western blot). : The expression of both receptors was higher in NSCLC than in NMLT. Higher MT1 and MT2 expression levels (at protein and mRNA) were noted in squamous cell carcinomas (SCC) compared to adenocarcinomas (AC). MT1 immunoexpression decreased as both the tumour size and the cancer stage increased in the whole cohort, while MT2 decreased as the cancer stage increased, with lymph node involvement (in the whole study group) and increasing malignancy grade (in SCC). Higher expression of MT2 was associated with a favorable prognosis. MT2 was an independent prognostic factor for overall survival (OS) in all analyzed NSCLC and in smoking patients. : Our observations may point to the potential prognostic significance of MT2 in NSCLC.</description><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Chemotherapy</subject><subject>Kinases</subject><subject>Lung cancer</subject><subject>Lymph nodes</subject><subject>Malignancy</subject><subject>Melatonin</subject><subject>Melatonin receptors</subject><subject>Metastasis</subject><subject>mRNA</subject><subject>Mutation</subject><subject>Non-small cell lung carcinoma</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>Radiation</subject><subject>Small cell lung carcinoma</subject><subject>Smoking</subject><subject>Squamous cell carcinoma</subject><subject>Transcription factors</subject><subject>Tumor cell lines</subject><subject>Tumors</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkUtLJDEUhYMo06KuZyeB2eiixrw6qWwEKdQR2gfTvZpNSOfRU1KVtEmV4L83o07Tehe5gfvdwz0cAL5j9JNSic6MDsaljDESGCG8A_YJEqTiXLLdrf8EHOX8iEpRigUX38CEYoolR2If_HlIcRViHloDb_q1NgOMHt66Tg8xtAH-dsath5gyvF1gqIMtncAyuIuhmve662DjyjMbwwo2bwfBk7t5M2tOD8Ge1112Rx_9ACyuLhfNr2p2f33TXMwqwwgeKo-oYIxwK5cG1bz2lNEasZoxhrhxU-u8WHpkuZFkaizH0mHtuWfWSSstPQDn77Lrcdk7a1wYku7UOrW9Ti8q6lZ9noT2r1rFZ8W5kBjVReDkQyDFp9HlQfVtNsWUDi6OWRHCMWGU1qygP76gj3FMobhTZMoEk0QgUaizd8qkmHNyfnMMRupfcupLcmXjeNvDhv-fE30FbRGTYA</recordid><startdate>20190717</startdate><enddate>20190717</enddate><creator>Jablonska, Karolina</creator><creator>Nowinska, Katarzyna</creator><creator>Piotrowska, Aleksandra</creator><creator>Partynska, Aleksandra</creator><creator>Katnik, Ewa</creator><creator>Pawelczyk, Konrad</creator><creator>Glatzel-Plucinska, Natalia</creator><creator>Podhorska-Okolow, Marzenna</creator><creator>Dziegiel, Piotr</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8292-1385</orcidid><orcidid>https://orcid.org/0000-0003-4093-7386</orcidid><orcidid>https://orcid.org/0000-0002-4618-9668</orcidid><orcidid>https://orcid.org/0000-0001-8275-7266</orcidid><orcidid>https://orcid.org/0000-0002-6498-717X</orcidid><orcidid>https://orcid.org/0000-0001-6901-1240</orcidid><orcidid>https://orcid.org/0000-0002-7989-3264</orcidid><orcidid>https://orcid.org/0000-0001-8316-8893</orcidid><orcidid>https://orcid.org/0000-0002-7532-0397</orcidid><orcidid>https://orcid.org/0000-0003-2215-5997</orcidid></search><sort><creationdate>20190717</creationdate><title>Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC)</title><author>Jablonska, Karolina ; Nowinska, Katarzyna ; Piotrowska, Aleksandra ; Partynska, Aleksandra ; Katnik, Ewa ; Pawelczyk, Konrad ; Glatzel-Plucinska, Natalia ; Podhorska-Okolow, Marzenna ; Dziegiel, Piotr</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-f0374426d9bc0868f343804844406ce5def7bf0d6c925cd619e1af6f4de9d9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Chemotherapy</topic><topic>Kinases</topic><topic>Lung cancer</topic><topic>Lymph nodes</topic><topic>Malignancy</topic><topic>Melatonin</topic><topic>Melatonin receptors</topic><topic>Metastasis</topic><topic>mRNA</topic><topic>Mutation</topic><topic>Non-small cell lung carcinoma</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>Radiation</topic><topic>Small cell lung carcinoma</topic><topic>Smoking</topic><topic>Squamous cell carcinoma</topic><topic>Transcription factors</topic><topic>Tumor cell lines</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jablonska, Karolina</creatorcontrib><creatorcontrib>Nowinska, Katarzyna</creatorcontrib><creatorcontrib>Piotrowska, Aleksandra</creatorcontrib><creatorcontrib>Partynska, Aleksandra</creatorcontrib><creatorcontrib>Katnik, Ewa</creatorcontrib><creatorcontrib>Pawelczyk, Konrad</creatorcontrib><creatorcontrib>Glatzel-Plucinska, Natalia</creatorcontrib><creatorcontrib>Podhorska-Okolow, Marzenna</creatorcontrib><creatorcontrib>Dziegiel, Piotr</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>Biological Sciences</collection><collection>ProQuest research library</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jablonska, Karolina</au><au>Nowinska, Katarzyna</au><au>Piotrowska, Aleksandra</au><au>Partynska, Aleksandra</au><au>Katnik, Ewa</au><au>Pawelczyk, Konrad</au><au>Glatzel-Plucinska, Natalia</au><au>Podhorska-Okolow, Marzenna</au><au>Dziegiel, Piotr</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC)</atitle><jtitle>Cancers</jtitle><addtitle>Cancers (Basel)</addtitle><date>2019-07-17</date><risdate>2019</risdate><volume>11</volume><issue>7</issue><spage>1001</spage><pages>1001-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>: Several studies have investigated the inhibitory effect of melatonin on lung cancer cells. There are no data available on the prognostic impact of melatonin receptors MT1 and MT2 in non-small cell lung cancer (NSCLC). : Immunohistochemical studies of MT1 and MT2 were conducted on NSCLC (N = 786) and non-malignant lung tissue (NMLT) (N = 120) using tissue microarrays. Molecular studies were performed on frozen fragments of NSCLC (N = 62; real time PCR), NMLT (N = 24) and lung cancer cell lines NCI-H1703, A549 and IMR-90 (real time PCR, western blot). : The expression of both receptors was higher in NSCLC than in NMLT. Higher MT1 and MT2 expression levels (at protein and mRNA) were noted in squamous cell carcinomas (SCC) compared to adenocarcinomas (AC). MT1 immunoexpression decreased as both the tumour size and the cancer stage increased in the whole cohort, while MT2 decreased as the cancer stage increased, with lymph node involvement (in the whole study group) and increasing malignancy grade (in SCC). Higher expression of MT2 was associated with a favorable prognosis. MT2 was an independent prognostic factor for overall survival (OS) in all analyzed NSCLC and in smoking patients. : Our observations may point to the potential prognostic significance of MT2 in NSCLC.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>31319607</pmid><doi>10.3390/cancers11071001</doi><orcidid>https://orcid.org/0000-0002-8292-1385</orcidid><orcidid>https://orcid.org/0000-0003-4093-7386</orcidid><orcidid>https://orcid.org/0000-0002-4618-9668</orcidid><orcidid>https://orcid.org/0000-0001-8275-7266</orcidid><orcidid>https://orcid.org/0000-0002-6498-717X</orcidid><orcidid>https://orcid.org/0000-0001-6901-1240</orcidid><orcidid>https://orcid.org/0000-0002-7989-3264</orcidid><orcidid>https://orcid.org/0000-0001-8316-8893</orcidid><orcidid>https://orcid.org/0000-0002-7532-0397</orcidid><orcidid>https://orcid.org/0000-0003-2215-5997</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2019-07, Vol.11 (7), p.1001
issn 2072-6694
2072-6694
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6679108
source PubMed (Medline); Publicly Available Content Database
subjects Breast cancer
Cancer therapies
Chemotherapy
Kinases
Lung cancer
Lymph nodes
Malignancy
Melatonin
Melatonin receptors
Metastasis
mRNA
Mutation
Non-small cell lung carcinoma
Phosphorylation
Proteins
Radiation
Small cell lung carcinoma
Smoking
Squamous cell carcinoma
Transcription factors
Tumor cell lines
Tumors
title Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A12%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20Impact%20of%20Melatonin%20Receptors%20MT1%20and%20MT2%20in%20Non-Small%20Cell%20Lung%20Cancer%20(NSCLC)&rft.jtitle=Cancers&rft.au=Jablonska,%20Karolina&rft.date=2019-07-17&rft.volume=11&rft.issue=7&rft.spage=1001&rft.pages=1001-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers11071001&rft_dat=%3Cproquest_pubme%3E2261243384%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c421t-f0374426d9bc0868f343804844406ce5def7bf0d6c925cd619e1af6f4de9d9d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2547492707&rft_id=info:pmid/31319607&rfr_iscdi=true